Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation (Q39719073)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 June 2010
edit
Language Label Description Also known as
English
Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation
scientific article published on 6 June 2010

    Statements

    Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation (English)
    Haiqing Ma
    Yaojun Zhang
    Qijing Wang
    Yongqiang Li
    Hui Wang
    Jiancong Sun
    Minshan Chen
    Jianchuan Xia
    6 June 2010
    903-907

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit